130 related articles for article (PubMed ID: 29985540)
1. Drug-induced thrombotic microangiopathy: An updated systematic review, 2014-2018.
Saleem R; Reese JA; George JN
Am J Hematol; 2018 Sep; 93(9):E241-E243. PubMed ID: 29985540
[No Abstract] [Full Text] [Related]
2. Intravenous OxyContin-associated thrombotic microangiopathy treated successfully without plasma exchange.
Tate C; Mollee P
Med J Aust; 2015 Apr; 202(6):330-1. PubMed ID: 25832162
[No Abstract] [Full Text] [Related]
3. Proteasome inhibitor-associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature.
Nguyen MN; Nayernama A; Jones SC; Kanapuru B; Gormley N; Waldron PE
Am J Hematol; 2020 Sep; 95(9):E218-E222. PubMed ID: 32291777
[No Abstract] [Full Text] [Related]
4. Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange.
Sullivan MR; Danilov AV; Lansigan F; Dunbar NM
J Clin Apher; 2015 Oct; 30(5):308-10. PubMed ID: 25413611
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic agents and thrombotic microangiopathy.
Garcia G; Atallah JP
J Oncol Pharm Pract; 2017 Mar; 23(2):135-142. PubMed ID: 26854265
[TBL] [Abstract][Full Text] [Related]
6. Case report: thrombotic microangiopathy post-intravenous immunoglobulin in the context of BK nephropathy and renal transplantation.
Pan FF; Hidayati L; Hughes P; Murugasu A; Masterson R
Transplant Proc; 2014; 46(1):278-80. PubMed ID: 24507067
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic microangiopathy associated with Valproic acid toxicity.
Hebert SA; Bohan TP; Erikson CL; Swinford RD
BMC Nephrol; 2017 Aug; 18(1):262. PubMed ID: 28774273
[TBL] [Abstract][Full Text] [Related]
8. A severe case of bevacizumab-induced thrombotic microangiopathy.
Bektas M; Samancı NS; Cokgezer S; Keskin D; Demirelli FH
J Oncol Pharm Pract; 2019 Oct; 25(7):1754-1757. PubMed ID: 30253727
[TBL] [Abstract][Full Text] [Related]
9. THROMBOTIC MICROANGIOPATHY ASSOCIATED WITH OPANA ER INTRAVENOUS ABUSE A Case Report.
Jabr FI; Yu L
J Med Liban; 2016; 64(1):40-2. PubMed ID: 27169165
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitor associated thrombotic microangiopathy.
Yui JC; Van Keer J; Weiss BM; Waxman AJ; Palmer MB; D'Agati VD; Kastritis E; Dimopoulos MA; Vij R; Bansal D; Dingli D; Nasr SH; Leung N
Am J Hematol; 2016 Sep; 91(9):E348-52. PubMed ID: 27286661
[TBL] [Abstract][Full Text] [Related]
11. Drug-associated thrombotic microangiopathies.
Kreuter J; Winters JL
Semin Thromb Hemost; 2012 Nov; 38(8):839-44. PubMed ID: 23037985
[TBL] [Abstract][Full Text] [Related]
12. Frequency and characteristics of chemotherapy-associated thrombotic microangiopathy: Analysis from a large pharmacovigilance database.
Klomjit N; Evans R; Le TK; Wells SL; Ortega J; Green-Lingren O; Mazepa M; Sise ME; Jhaveri KD; Gupta S
Am J Hematol; 2023 Dec; 98(12):E369-E372. PubMed ID: 37740927
[TBL] [Abstract][Full Text] [Related]
13. Oxymorphone Induced Thrombotic Microangiopathy Mimicking Atypical Haemolytic Uremic Syndrome.
Gandhi A; Ullah S; Kotadia S; Nasser S
J Ayub Med Coll Abbottabad; 2017; 29(2):360-362. PubMed ID: 28718268
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathies and antineoplastic agents.
Grangé S; Coppo P;
Nephrol Ther; 2017 Apr; 13 Suppl 1():S109-S113. PubMed ID: 28577731
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab-induced thrombotic microangiopathy and nephrotic syndrome.
Shimamura Y; Maeda T; Takizawa H
Clin Exp Nephrol; 2019 Jan; 23(1):142-143. PubMed ID: 29882112
[No Abstract] [Full Text] [Related]
16. Cabozantinib-induced renal thrombotic microangiopathy.
La Manna G; Baraldi O; Corradetti V; Comai G
Nephrology (Carlton); 2018 Jan; 23(1):96-97. PubMed ID: 29250919
[No Abstract] [Full Text] [Related]
17. Clopidogrel-induced Thrombotic Microangiopathy in a Patient with Hypocomplementemia.
Tada K; Ito K; Hamauchi A; Takahashi K; Watanabe R; Uchida A; Abe Y; Yasuno T; Miyake K; Sasatomi Y; Nakashima H
Intern Med; 2016; 55(8):969-73. PubMed ID: 27086814
[TBL] [Abstract][Full Text] [Related]
18. De Novo Thrombotic Microangiopathy Immediately After Kidney Transplant in Patients Without Apparent Risk Factors.
Patel A; Knorr JP; Campos S; Khanmoradi K; Zaki RF; Bradauskaite G
Exp Clin Transplant; 2016 Apr; 14(2):230-4. PubMed ID: 26030297
[TBL] [Abstract][Full Text] [Related]
19. Carfilzomib: A cause of drug associated thrombotic microangiopathy.
Qaqish I; Schlam IM; Chakkera HA; Fonseca R; Adamski J
Transfus Apher Sci; 2016 Jun; 54(3):401-4. PubMed ID: 27017313
[TBL] [Abstract][Full Text] [Related]
20. Opana ER-induced thrombotic microangiopathy.
Lämmle B
Blood; 2017 Feb; 129(7):808-809. PubMed ID: 28209752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
